Gufic BioSciences opened higher at ₹439.90, compared with its previous close of ₹436.30. In the last trading session on 9 Nov 2026, the stock traded between ₹436.40 and ₹480.95, with an average traded price of ₹465.66. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Gufic BioSciences is now worth
₹ 25,558.00
giving a profit of
₹ 15,558.00 (155.58%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+38.05 (+8.72%)
Day High
₹480.95
Day Low
₹436.40
Day Open
₹439.90
Prev Close
₹436.30
Volume
7,61,521
Value Traded
₹35.46 Cr
1W Return
14.70%
1M Return
17.40%
3M Return
12.57%
6M Return
56.84%
1Y Return
42.00%
Market Cap (₹ Cr.)
4,757
PE Ratio
60.10
PB Ratio
6.64
Dividend Yield
0.02%
ROE
9.66%
ROCE
14.94%
Book Value (₹)
66.31
Face Value (₹)
1.00
EPS (TTM)
2.22
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
14.70%
6 Weeks
-
1 Month
17.40%
3 Months
12.57%
9 Months
53.98%
Gufic BioSciences gets ITAT order for fresh tax assessment in AY 23-24
ITAT Mumbai restored AY 2023-24 assessment to Assessing Officer for fresh review. Original tax demand of ₹11,88,88,580 was reduced to ₹11,76,198 by CIT(A). No immediate demand arises; final liability pending fresh assessment completion. Tribunal allowed both Department’s appeal and Company’s cross-objection statistically.
6 days agoGufic BioSciences wins appeal against ₹4.33 crore tax demand
Gufic BioSciences won an appeal against a ₹4.33 crore income tax demand for AY 2024-25. The Commissioner of Income Tax (Appeals) passed the order on September 28, 2026. The demand arose from disallowance of expenditure under Section 143 of the Income Tax Act. The order results in the complete deletion of the ₹4.33 crore liability.
1mo agoGufic BioSciences receives CRISIL ESG rating of 62 for FY26
Gufic BioSciences received a CRISIL ESG rating of 62 (Strong) for FY26. The rating was assigned independently by Crisil based on public domain data. The company did not engage Crisil for this specific ESG assessment. Disclosure made under SEBI LODR Regulation 30(6) and related master circulars.
1mo agoGufic Biosciences to pay ₹1.72 lakh NSE penalty after waiver rejection
NSE rejected Gufic Biosciences' waiver application for a ₹1,72,000 penalty. Payment deadline set for October 3, 2026, following September 23, 2026 rejection. Non-compliance involved appointing a director over 75 without special resolution. BSE had previously rejected a similar waiver in March 2026.
1mo agoGufic Biosciences shareholders approve all AGM resolutions including dividend
Gufic Biosciences shareholders approved all five resolutions at its 42nd AGM held on September 4, 2026. A 10% final dividend of ₹0.10 per share was declared for FY26. Promoter group voted 100% in favor across all resolutions. Mr. Pranav J. Choksi re-appointed as director; Mr. Pankaj J. Gandhi continues as WTD beyond age 70. Total voting turnout was 79.94% with 43 shareholders participating.
2mo agoGufic Biosciences promotes Ami Shah, Pinak Padhya to senior roles
Ms. Ami Shah promoted to Head-Legal while retaining Company Secretary role. Mr. Pinak Padhya elevated to President – Sales & Marketing from Vice President. Changes effective September 2, 2026 following board approval. Disclosures made under Regulation 30 of SEBI Listing Regulations 2015.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,904.50 | +0.00% | ₹4,56,953.35 | 41.60 | +12.60% | |
| ₹11,565.50 | +0.00% | ₹3,07,027.69 | 91.30 | +73.75% | |
| ₹4,780.00 | +0.00% | ₹1,81,815.84 | 86.50 | +33.52% | |
| ₹2,454.00 | +0.00% | ₹1,32,592.62 | 99.30 | +149.86% | |
| ₹1,215.90 | +0.00% | ₹1,21,286.49 | 28.10 | +28.79% | |
| ₹1,385.00 | +0.00% | ₹1,15,603.22 | 41.90 | +14.90% | |
| ₹1,403.80 | +0.00% | ₹1,13,407.17 | 39.80 | -6.77% | |
| ₹2,668.30 | +0.00% | ₹1,10,212.82 | 48.60 | +17.97% | |
| ₹1,855.30 | +0.38% | ₹1,06,749.86 | 26.70 | +65.09% | |
| ₹2,025.00 | +0.00% | ₹92,601.22 | 17.60 | +2.70% | |
| ₹2,671.10 | +0.00% | ₹75,385.03 | 52.10 | +47.45% | |
| ₹5,398.50 | +0.00% | ₹64,547.17 | 29.30 | -4.76% |
An investment of ₹10,000 made 5 years ago in Gufic BioSciences is now worth
₹ 25,558.00
giving a profit of
₹ 15,558.00 (155.58%)
Note: Past profits do not guarantee future returns.